Orchid gets US FDA approval for its drug
February 20th, 2008 - 7:17 pm ICT by admin
-
Mumbai Feb 20 (IANS) Orchid Chemicals and Pharmaceuticals Ltd Wednesday said it has received an approval from US Food and Drug Administration (US FDA) for its Cefuroxime Axetil tablets. Orchid’s statement to the Bombay Stock Exchange (BSE,) said the product, falling under the ANDA (Abbreviated New Drug Application), is available in three dosage strengths, 125 mg, 250 mg and 500 mg.
According to company officials, this is the 25th ANDA approval that the company has received since it started its US Generics journey in 2005.
Last week the Chennai-based pharma company had announced about the approval from US FDA in regard to its anti-emetic and non-antibiotic Granisetron Hydrochloride tablets. The product is available in 1 mg dosage strength.
Sphere: Related ContentRelated Stories
- Lupin receives US approval for another drug - Jul 31, 2008
- Ranbaxy gets USFDAs permission to manufacture cardiovascular drugs - Mar 09, 2009
- Sun Pharma gets US nod for women's drug - Sep 12, 2008
- Aurobindo Pharma gets US approval for HIV tablets - Sep 17, 2008
- Sun Pharma gets US approval for Paraplatin injection - Sep 23, 2008
- Glenmark gets US nod for sale of arthritis drug - Mar 13, 2008
- US nod to Glenmark's blood pressure drug - Jun 20, 2008
- US drug officials raid Sun Pharma's facilities - Jun 26, 2009
- IPCA gets green signal from US for blood pressure drug - Jun 04, 2008
- Did Ranbaxy distribute suspect drugs? US House panel to probe - Jul 18, 2008
- abbreviated new drug application- - anda approval
- - anti emetic
- - bombay stock exchange
- - bse
- - cefuroxime
- - cefuroxime axetil tablets
- - company officials
- - dosage strengths
- - fda
- - food and drug
- - food and drug administration
- - granisetron
- - granisetron hydrochloride
- - mg dosage strength
- - orchid chemicals
- - pharma company
- - pharmaceuticals
- - regard
- - us fda approval
Posted in Health Science, |
